J. Tchamgoue, Amelework N. Eyado, Boniface P. Kamdem Kamdem, Y. A. Ngandjui, J. Tchouankeu, S. Kouam, Y. Mekonnen
{"title":"胡氏假关节炎的体内抗疟原虫特性及黄酮类化合物研究。(豆科)","authors":"J. Tchamgoue, Amelework N. Eyado, Boniface P. Kamdem Kamdem, Y. A. Ngandjui, J. Tchouankeu, S. Kouam, Y. Mekonnen","doi":"10.53365/nrfhh/145411","DOIUrl":null,"url":null,"abstract":"Malaria is regarded as one of the most lethal diseases. Resistance to artemisinin and its derivatives jeopardises effective malaria treatment. Finding novel antimalarial chemicals is critical given the existing treatment situation. This work aimed to examine the antiplasmodial capabilities of Pseudarthria hookeri fractions and flavonoids in vivo. The fractions and compounds antiplasmodial activity were evaluated on male Swiss albino mice infected with Plasmodium berghei, and on healthy female Swiss albino mice, the crude extract's acute toxicity was assessed. The EtOAc fraction had significant antiplasmodial activity (32.53 percent suppression at 500 mg/kg BW) and considerably prolonged the survival period of infected mice (9.8 days) compared to control mice (7.8 days). Parasitaemia was dramatically reduced (85.01, 59.41, and 70.39 percent), and the mean survival time extended (11.33, 10.00, and 9.33 days) with 15, 20 and 35 mg/kg of quercetin (1), 7-O-benzyl-6-prenylpinocembrin (6) and 6,8-diprenyleriodictyol (11) (isolates of the EtOAc fraction), respectively. BW loss and PCV reduction were also averted. Moreover, at 2500 mg/kg, the crude extract of P. hookeri showed no acute toxicity in mice. LC-MS analysis of the EtOAc fraction enabled the identification of nine flavonoids, with 8 and 11 being the main components. The present investigation confirmed P. hookeri's antiplasmodial action, substantiating its ethnomedicinal application for malaria treatment.","PeriodicalId":394827,"journal":{"name":"Natural Resources for Human Health","volume":"79 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In vivo antiplasmodial properties of fractions and flavonoids of Pseudarthria hooheri Wight & Arn. (Fabaceae)\",\"authors\":\"J. Tchamgoue, Amelework N. Eyado, Boniface P. Kamdem Kamdem, Y. A. Ngandjui, J. Tchouankeu, S. Kouam, Y. Mekonnen\",\"doi\":\"10.53365/nrfhh/145411\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Malaria is regarded as one of the most lethal diseases. Resistance to artemisinin and its derivatives jeopardises effective malaria treatment. Finding novel antimalarial chemicals is critical given the existing treatment situation. This work aimed to examine the antiplasmodial capabilities of Pseudarthria hookeri fractions and flavonoids in vivo. The fractions and compounds antiplasmodial activity were evaluated on male Swiss albino mice infected with Plasmodium berghei, and on healthy female Swiss albino mice, the crude extract's acute toxicity was assessed. The EtOAc fraction had significant antiplasmodial activity (32.53 percent suppression at 500 mg/kg BW) and considerably prolonged the survival period of infected mice (9.8 days) compared to control mice (7.8 days). Parasitaemia was dramatically reduced (85.01, 59.41, and 70.39 percent), and the mean survival time extended (11.33, 10.00, and 9.33 days) with 15, 20 and 35 mg/kg of quercetin (1), 7-O-benzyl-6-prenylpinocembrin (6) and 6,8-diprenyleriodictyol (11) (isolates of the EtOAc fraction), respectively. BW loss and PCV reduction were also averted. Moreover, at 2500 mg/kg, the crude extract of P. hookeri showed no acute toxicity in mice. LC-MS analysis of the EtOAc fraction enabled the identification of nine flavonoids, with 8 and 11 being the main components. The present investigation confirmed P. hookeri's antiplasmodial action, substantiating its ethnomedicinal application for malaria treatment.\",\"PeriodicalId\":394827,\"journal\":{\"name\":\"Natural Resources for Human Health\",\"volume\":\"79 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Natural Resources for Human Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53365/nrfhh/145411\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Natural Resources for Human Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53365/nrfhh/145411","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
疟疾被认为是最致命的疾病之一。对青蒿素及其衍生物的耐药性危及疟疾的有效治疗。鉴于现有的治疗情况,寻找新的抗疟药物至关重要。本研究旨在研究假构草和黄酮类化合物在体内的抗疟原虫能力。对感染伯氏疟原虫的雄性瑞士白化小鼠和健康的瑞士白化雌性小鼠进行了急性毒性评价。EtOAc组分具有显著的抗疟原虫活性(500 mg/kg BW时抑制32.53%),与对照小鼠(7.8天)相比,感染小鼠的生存期(9.8天)大大延长。15、20和35 mg/kg槲皮素(1)、7- o -苄基-6-烯丙基匹诺松素(6)和6,8-二烯丙基匹诺松醇(11)(EtOAc分离物)分别显著降低了寄生率(85.01、59.41和70.39%),延长了平均生存时间(11.33、10.00和9.33 d)。BW损失和PCV减少也得以避免。此外,2500 mg/kg的粗提物对小鼠无急性毒性。对乙酸乙酯组分进行LC-MS分析,鉴定出9种黄酮类化合物,其中8和11为主要成分。本研究证实了虎氏单胞菌的抗疟原虫作用,证实了其在疟疾治疗中的民族医药应用。
In vivo antiplasmodial properties of fractions and flavonoids of Pseudarthria hooheri Wight & Arn. (Fabaceae)
Malaria is regarded as one of the most lethal diseases. Resistance to artemisinin and its derivatives jeopardises effective malaria treatment. Finding novel antimalarial chemicals is critical given the existing treatment situation. This work aimed to examine the antiplasmodial capabilities of Pseudarthria hookeri fractions and flavonoids in vivo. The fractions and compounds antiplasmodial activity were evaluated on male Swiss albino mice infected with Plasmodium berghei, and on healthy female Swiss albino mice, the crude extract's acute toxicity was assessed. The EtOAc fraction had significant antiplasmodial activity (32.53 percent suppression at 500 mg/kg BW) and considerably prolonged the survival period of infected mice (9.8 days) compared to control mice (7.8 days). Parasitaemia was dramatically reduced (85.01, 59.41, and 70.39 percent), and the mean survival time extended (11.33, 10.00, and 9.33 days) with 15, 20 and 35 mg/kg of quercetin (1), 7-O-benzyl-6-prenylpinocembrin (6) and 6,8-diprenyleriodictyol (11) (isolates of the EtOAc fraction), respectively. BW loss and PCV reduction were also averted. Moreover, at 2500 mg/kg, the crude extract of P. hookeri showed no acute toxicity in mice. LC-MS analysis of the EtOAc fraction enabled the identification of nine flavonoids, with 8 and 11 being the main components. The present investigation confirmed P. hookeri's antiplasmodial action, substantiating its ethnomedicinal application for malaria treatment.